rs121918153
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM5PP5_Very_Strong
The NM_000312.4(PROC):c.659G>A(p.Arg220Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,960 control chromosomes in the GnomAD database, including 1 homozygotes. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R220W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000312.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251324Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135872
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461742Hom.: 1 Cov.: 31 AF XY: 0.0000770 AC XY: 56AN XY: 727178
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74368
ClinVar
Submissions by phenotype
Thrombophilia due to protein C deficiency, autosomal dominant Pathogenic:4
The PROC c.659G>A (p.Arg220Gln) variant has been reported in six studies in which it is found in a total of 30 individuals with protein C deficiency, all in a heterozygous state (Gandrille et al. 1992; Grundy et al. 1992; Poort et al. 1993; Millar et al. 1995; Soria et al. 1996; Couture et al. 1998). The p.Arg220Gln variant was absent from 50 ethnically matched controls and is reported at a frequency of 0.00067 in the South Asian population of the Exome Aggregation Consortium. Based on the evidence, the p.Arg220Gln is classified as pathogenic for protein C deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Variant summary: PROC c.659G>A (p.Arg220Gln) results in a conservative amino acid change located in the Serine proteases, trypsin domain (IPR001254) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 9.5e-05 in 251324 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in PROC causing Thrombophilia Due To Protein C Deficiency, Autosomal Dominant, allowing no conclusion about variant significance. c.659G>A has been reported in the literature in multiple individuals affected with Thrombophilia Due To Protein C Deficiency, Autosomal Dominant (Grundy_1992, Miyata_2009, Martos_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 1511989, 31254973, 18954896, 1868249, 32309994). ClinVar contains an entry for this variant (Variation ID: 669). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 220 of the PROC protein (p.Arg220Gln). This variant is present in population databases (rs121918153, gnomAD 0.06%). This missense change has been observed in individuals with protein C deficiency (PMID: 1301954, 1301959, 1511989, 7605880, 8499565, 18954896, 31254973). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg178Gln. ClinVar contains an entry for this variant (Variation ID: 669). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PROC protein function with a negative predictive value of 80%. This variant disrupts the p.Arg220 amino acid residue in PROC. Other variant(s) that disrupt this residue have been observed in individuals with PROC-related conditions (PMID: 1868249, 2602169, 7605880, 21621249), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
PP1_moderate, PM1, PM2_moderate, PS3_moderate, PS4 -
- -
Reduced protein C activity Pathogenic:1
- -
Thrombophilia due to protein C deficiency, autosomal dominant;C2676759:Thrombophilia due to protein C deficiency, autosomal recessive Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at